Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Study of Markers of Angiogenesis and Coagulability in Patients With Monoclonal Gammopathy

NCT01543100 is registered in ClinicalTrials.gov with Rennes University Hospital as lead sponsor.

NCT NCT01543100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01543100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Study of Markers of Angiogenesis and Coagulability in Patients With Monoclonal Gammopathy
Lead sponsor
Rennes University Hospital
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2010
Completion date
January 31, 2014
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

monoclonal gammopathy, monoclonal gammopathy of undetermined signification, myeloma